V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003707 | 320002249 | 1.61 | 121 | null | 2016-02-25 | 2016-02-28 | Oxaliplatin + Modified de Gramont | 2 | N | 320023819 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003708 | 320002250 | 1.62 | 57.8 | Palliative (P) | 2013-12-19 | 2013-12-25 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 320023837 | GEMCITABINE + PACLITAXEL |
| 320003709 | 320002251 | 1.64 | 104.4 | Palliative (P) | 2017-12-28 | 2018-01-07 | CARBOPLATIN + RT | N | N | 320023838 | CAPECITABINE + OXALIPLATIN |
| 320003710 | 320002252 | 1.72 | 97.8 | null | 2018-06-10 | 2018-07-08 | Cisplatin + Docetaxel +Fluorouracil | 2 | Y | 320023849 | CAPECITABINE + CISPLATIN |
| 320003711 | 320002253 | 1.76 | 80.6 | Neo-adjuvant (N) | 2017-09-25 | 2017-10-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320023850 | CARBOPLATIN + ETOPOSIDE |
| 320003712 | 320002254 | null | 85 | Adjuvant (A) | null | 2015-04-08 | CARBOPLATIN + ETOPOSIDE | Y | N | 320023851 | ENZALUTAMIDE |
| 320003713 | 320002255 | 1.76 | 118 | Neo-adjuvant (N) | 2017-07-14 | 2017-07-21 | Carboplatin + Pemetrexed | N | N | 320023853 | EOX |
| 320003714 | 320002256 | null | 81.4 | Palliative (P) | 2017-12-17 | 2017-12-26 | CAPECITABINE + TEMOZOLOMIDE | 01 | N | 320023854 | CETUXIMAB |
| 320003715 | 320002256 | 1.65 | 60 | Palliative (P) | 2018-04-11 | 2018-04-24 | Bevacizumab 7.5mg/kg | N | N | 320023854 | NOT MATCHED |
| 320003716 | 320002257 | 1.75 | 55.2 | Curative (C) | 2017-08-26 | 2017-08-30 | BCG Intravesical | N | N | 320023866 | NOT MATCHED |
| 320003717 | 320002258 | null | 44.2 | Disease modification (D) | 2015-10-29 | 2015-11-15 | CompARE Trial | N | N | 320023872 | GEMCITABINE |
| 320003718 | 320002258 | 1.58 | 69.6 | Neo-adjuvant (N) | 2015-12-10 | 2015-12-19 | CETUXIMAB + RT | N | N | 320023872 | IMATINIB |
| 320003719 | 320006371 | 1.5 | 59.8 | Curative (C) | 2014-01-25 | 2014-02-08 | Bevacizumab+Carbo+Gemcitabine | N | N | 320023884 | CAPECITABINE + CISPLATIN |
| 320003720 | 320006371 | 1.76 | 116.4 | Not known (9) | 2016-01-29 | 2016-02-08 | CETUXIMAB + RT | N | N | 320023884 | TRIAL |
| 320003721 | 320006371 | 1.6 | 45 | Palliative (P) | null | 2017-10-03 | Ipilimumab | N | N | 320023884 | TEMOZOLOMIDE |
| 320003722 | 320002259 | 1.65 | 68 | Neo-adjuvant (N) | 2013-06-26 | 2013-07-09 | BCG Intravesical | 02 | N | 320023899 | TEMOZOLOMIDE + RT |
| 320003723 | 320002260 | 1.73 | 59.4 | Palliative (P) | 2017-05-03 | 2017-05-11 | Carboplatin + Liposomal Doxorubicin | N | N | 320023905 | OXALIPLATIN + MDG |
| 320003724 | 320002261 | 1.91 | 78.7 | Adjuvant (A) | 2017-07-17 | 2017-07-26 | Docetaxel | 01 | N | 320023908 | CARBOPLATIN + RT |
| 320003725 | 320005066 | 1.8 | 90.3 | Palliative (P) | 2015-08-08 | 2015-08-18 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320023911 | POUT TRIAL |
| 320003726 | 320002262 | 1.6 | 73 | Adjuvant (A) | 2017-08-14 | 2017-08-25 | Ipilimumab | N | N | 320023912 | CARBO + FLUOROURACIL |
| 320003727 | 320002263 | 1.61 | 76.9 | Curative (C) | 2015-05-26 | 2015-05-30 | Bevacizumab 7.5mg/kg | 02 | N | 320023917 | CETUXIMAB + RT |
| 320003728 | 320002264 | null | null | Neo-adjuvant (N) | 2016-08-18 | 2016-08-30 | Temozolomide + RT | N | N | 320023921 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 320003729 | 320002264 | 1.66 | 90 | Palliative (P) | 2014-11-21 | 2014-12-02 | CYCLOPHOSPHAMIDE | N | N | 320023921 | CARBO + FLUOROURACIL |
| 320003730 | 320002265 | 1.7 | 62.3 | Palliative (P) | 2015-04-13 | 2015-04-25 | CISPLATIN + GEMCITABINE | N | N | 320023924 | BEVACIZUMAB |
| 320003731 | 320002265 | 1.68 | 63.6 | Palliative (P) | 2015-10-22 | 2015-11-06 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 320023924 | GEMCITABINE + RT |
| 320003732 | 320002265 | 1.58 | 91.4 | Adjuvant (A) | 2014-12-22 | 2015-01-17 | ICON8 TRIAL | N | N | 320023924 | CARBOPLATIN + PEMETREXED |
| 320003733 | 320002266 | 1.89 | 93 | Palliative (P) | 2017-05-02 | 2017-05-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320023934 | CAPECITABINE |
| 320003734 | 320002267 | 1.59 | 56.9 | Neo-adjuvant (N) | null | 2017-12-14 | ICON8 TRIAL | N | N | 320023940 | NOT MATCHED |
| 320003735 | 320002267 | 1.5 | 54.25 | Palliative (P) | 2014-08-22 | 2014-08-29 | ECX | 02 | N | 320023940 | ICON TRIAL |
| 320003736 | 320002267 | 1.72 | 0 | Palliative (P) | 2015-01-20 | 2015-01-22 | Temozolomide + RT | 2 | N | 320023940 | TRIAL |
| 320003737 | 320002268 | 1.54 | 90.6 | null | 2014-12-13 | 2014-12-24 | EOX | null | null | 320023950 | CAPECITABINE + CISPLATIN |
| 320003738 | 320002268 | 1.58 | 81.6 | Palliative (P) | 2015-06-25 | 2015-07-04 | Imatinib 400mg | N | N | 320023950 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320003739 | 320002269 | 1.77 | 85.7 | Curative (C) | 2017-11-04 | 2017-11-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320023954 | SUNITINIB |
| 320003740 | 320002270 | 1.62 | 72 | Palliative (P) | 2015-08-01 | 2015-02-08 | Bevacizumab | null | N | 320023957 | CARBOPLATIN + PEMETREXED |
| 320003741 | 320002270 | 1.73 | 66.7 | Palliative (P) | 2015-05-15 | 2015-05-16 | Cetuximab + Radiotherapy Load | N | N | 320023957 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003742 | 320002271 | 1.76 | 98 | Adjuvant (A) | 2014-02-09 | 2014-03-31 | IMATINIB | 01 | N | 320023962 | BCG |
| 320003743 | 320002272 | null | 56.6 | Adjuvant (A) | null | 2016-08-23 | Ipilimumab | null | null | 320023963 | PEMBROLIZUMAB |
| 320003744 | 320002273 | 1.67 | 75.4 | Adjuvant (A) | 2014-04-17 | 2014-04-23 | FLUOROURACIL + IRINOTECAN | Y | N | 320023968 | CISPLATIN + PEMETREXED |
| 320003745 | 320002274 | 1.61 | 51.8 | Curative (C) | 2014-03-04 | 2014-03-15 | Trial Unspecified | null | N | 320023973 | DOXORUBICIN |
| 320003746 | 320002275 | 0 | 97.4 | Palliative (P) | 2016-05-29 | 2016-06-07 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 320023980 | CISPLATIN + GEMCITABINE |
| 320003747 | 320002276 | 1.82 | 92.2 | Palliative (P) | null | 2016-07-02 | Cisplatin + Docetaxel +Fluorouracil | null | null | 320023981 | CISPLATIN + ETOPOSIDE |
| 320003748 | 320002276 | 1.78 | 73.2 | Palliative (P) | 2017-11-04 | 2017-11-11 | Carbo F | N | N | 320023981 | CAPECITABINE + CISPLATIN |
| 320003749 | 320002277 | 1.7 | 0 | Curative (C) | 2016-03-21 | 2016-04-22 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | Y | 320023986 | CARBOPLATIN + ETOPOSIDE |
| 320003750 | 320002278 | 1.57 | 51.9 | Adjuvant (A) | 2015-05-25 | 2015-06-10 | CAPECITABINE + OXALIPLATIN | N | Y | 320023988 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 320003751 | 320002278 | null | 58 | Adjuvant (A) | 2014-06-28 | 2014-07-28 | CISPLATIN + GEMCITABINE | null | Y | 320023988 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003752 | 320002278 | 1.75 | 56.7 | Palliative (P) | 2017-05-28 | 2017-06-07 | EOX | N | N | 320023988 | CARBO + FLUOROURACIL |
| 320003753 | 320002278 | 1.72 | 123.4 | Curative (C) | 2014-06-08 | 2014-06-29 | POUT TRIAL | N | Y | 320023988 | CETUXIMAB + RT |
| 320003754 | 320002279 | 1.52 | 44.9 | Adjuvant (A) | null | 2016-01-22 | Epirubicin | N | N | 320023997 | BEVACIZUMAB |
| 320003755 | 320002280 | 1.59 | 74.7 | Palliative (P) | 2016-10-05 | 2016-10-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320024003 | TEMOZOLOMIDE + RT |
| 320003756 | 320002280 | 1.73 | 85 | Adjuvant (A) | 2017-07-23 | 2017-07-23 | Fluorouracil + Folinic Acid Weekly | 02 | N | 320024003 | BCG |